WebOct 2, 2014 · The Cryptogenic Stroke and Underlying AF (CRYSTAL AF) trial [] is a prospective, multicenter randomized controlled trial conducted between June 2009 and April 2012, aimed at assessing whether long-term monitoring with an implanted cardiac monitor (ICM) is more effective than conventional follow-up for detecting episodes of AF after … WebApr 11, 2024 · The HAVOC score was previously developed to predict the risk of atrial fibrillation (AF) after cryptogenic stroke (CS) or transient ischemic attack (TIA). The …
Real-World Experience with Insertable Cardiac Monitors to Find …
WebSep 9, 2014 · In the CRYSTAL AF trial, by the sixth month, new AF was detected in 8.9% of patients with implantable cardiac monitor when compared with 1.4% among those … WebThe AF detection rate in our cohort was compared to the rate in CRYSTAL-AF Trial at 36-month follow-up. The impact of AF detection on clinical management was examined. Results: We identified 225 patients. 51.1% were women and 38.2% African American. Among 85 patients with ILR labeled AF, 43 patients had true AF, and 42 had incorrectly labeled ... razor character icon
Predictors of atrial fibrillation on implantable cardiac ... - PubMed
Web(CRYSTAL AF),3 an international randomized controlled trial, reported the use of insertable car-diac monitors (ICMs) for long-term monitoring in post-CS patients. In CRYSTAL AF, … WebIn CRYSTAL-AF, moreover, the stroke rate at 1 year was lower in participants randomly assigned to the implantable cardiac monitor (ICM) arm compared with those assigned to conventional monitoring (7.1% vs 9.1%, P >.05), although the … WebMar 29, 2024 · External validation of biomarkers predictive of AF was performed using 83 patients with ESUS who were implanted with insertable cardiac monitors. Results: The 7-day Holter monitoring started at a median of 13 days after the onset of stroke. AF was detected in 14 patients, and three of these showed a single AF episode lasting <2 min. razor character sheet